Diversity and Recognition Efficiency of T Cell Responses to Cancer (2004)
Tor B. Stuge, Susan P. Holmes, Sahdev Saharan, Andrea Tuettenberg, Mario Roederer, Jeffrey S. Weber, ...
State-of-the art analysis of patients' response to melanoma vaccines yields lessons about cancer vaccines and rationale vaccine design in general.
Diversity and Recognition Efficiency of T Cell Responses to Cancer (2004)
Tor B. Stuge, Susan P. Holmes, Sahdev Saharan, Andrea Tuettenberg, Mario Roederer, Jeffrey S. Weber, ...
Background Melanoma patients vaccinated with tumor-associated antigens frequently develop measurable peptide-specific CD8+ T cell responses; however, such responses often do not confer clinical...
Diversity and Recognition Efficiency of T Cell Responses to Cancer
Stuge, Tor B, Holmes, Susan P, Saharan, Sahdev, Tuettenberg, Andrea, Roederer, Mario, Weber, Jeffrey S, ...
State-of-the art analysis of patients' response to melanoma vaccines yields lessons about cancer vaccines and rationale vaccine design in general
Diversity and Recognition Efficiency of T Cell Responses to Cancer
Stuge, Tor B, Holmes, Susan P, Saharan, Sahdev, Tuettenberg, Andrea, Roederer, Mario, Weber, Jeffrey S, ...
State-of-the art analysis of patients' response to melanoma vaccines yields lessons about cancer vaccines and rationale vaccine design in general
Jonuleit, Helmut, Schmitt, Edgar, Stassen, Michael, Tuettenberg, Andrea, Knop, Jurgen, Enk, Alexander H.
A subpopulation of peripheral human CD4+CD25+ T cells that expresses CD45RO, histocompatibility leukocyte antigen DR, and intracellular cytotoxic T lymphocyte–associated antigen (CTLA) 4 does not...